Additionally, data associated with the GeneStrat® ddPCR™ and Genestrat NGS™ blood tests will be presented at the American Association for Cancer Research (AACR) BOULDER, Colo., March 29, 2022–Biodesix, Inc. (NASDAQ: BDSX), a leading data-driven diagnostic solutions company with … Continue reading Biodesix (NASDAQ: BDSX) Announces Publication Further Validating the Use of Liquid Biopsies and NGS Techniques to Provide Clinical Information for Patients With Cancer